Health
AstraZeneca’s trial illnesses may not be due to Covid-19 shot, says Oxford University – Hindustan Times
The vaccine trials have resumed in Britain, Brazil and South Africa, but not yet in the United States.
The adverse events that led to a pause in trials evaluating AstraZeneca Plc’s Covid-19 vaccine candidate may not have been associated with the vaccine itself, according to a document outlining participant information that was posted online by the Oxford University.
Also read:Oxford’s coronavirus vaccine AstraZeneca trial resumes after UK green light
Enrollment in the British drugmaker’s global trials of the vaccine, which it is developing with researchers at Oxford University, was paused on Se…
-
General16 hours ago‘We are here for you’: PM to bring help to flood zones
-
General14 hours agoWe’ve all talked about potential economic consequences for Australia of Trump’s policies. Now they’re happening
-
Noosa News22 hours agoStudents say new facility would be better in rural areas of Queensland
-
General13 hours ago‘I can’t start at zero now’: Aussies call for clarity after super cyber attack